{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-025438","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2025-08-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.481112+00:00","generated_at":"2026-05-17T09:56:54.573720+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BriaCell Therapeutics announces 1-for-10 reverse stock split effective August 25, 2025 to maintain Nasdaq listing","bullets":["Share consolidation of 1 post-split share for every 10 pre-split shares, effective August 25, 2025.","Post-consolidation common shares trade on Nasdaq (BCTX) and TSX (BCT) under same symbols.","Consolidation intended to ensure continued compliance with Nasdaq listing requirements.","No fractional shares issued; fractions less than 0.5 cancelled, 0.5 or greater rounded up to one share.","Outstanding convertible securities' exercise/conversion prices proportionately adjusted."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-025438","json":"https://secwatch.observer/filing/0001641172-25-025438.json","markdown":"https://secwatch.observer/filing/0001641172-25-025438.md","text":"https://secwatch.observer/filing/0001641172-25-025438.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000164117225025438/0001641172-25-025438-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000164117225025438/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:56:54.573720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}